Close Menu

NYGC

The researchers applied their so-called GWAX approach to study 12 common diseases in almost 120,000 individuals, confirming known and uncovering novel disease risk loci.

The center plans to offer the test for patients with undiagnosed disease and for disease predisposition testing in ostensibly healthy individuals.

The partners have committed to analyzing coding mutations, driver non-coding mutations, and structural variations across tumor types for the project.

Seeq has much in common with DNA.Land, launched last year, but targets individuals who have not used services from direct-to-consumer testing companies

Data from 43 genome-wide association studies have led researchers to individual variants and genetic factors that influence multiple phenotypes and conditions.

The partners plan to build a comprehensive repository that will contain genomic, exome, and phenotype data collected first from about 200 cancer patients. 

Dozens of government agencies, academic institutions, and a various public and private sector organizations have now committed to driving the initiative forward.

The Simons Foundation and the Carson Family Charitable Trust will match every dollar raised by the NYGC over the next three years up to $100 million.

As part of a course this fall, 20 undergraduate and graduate students used the MinIon in two hands-on "hackathon" sequencing projects.

New York Genome Center-led researchers have found that short tandem repeats may regulate gene expression rather than representing neutral variation.

Pages

Public health experts call for a transparent COVID-19 vaccine approval process in a letter; the Food and Drug Administration commissioner assures science-based approval.

The Verge reports that new gene-naming guidelines aim in part to avoid Excel-related name change confusion.

In Nature this week: tuatara genome sequence aids in understanding amniote evolution, and more.

According to the Guardian, UK virologists say in a letter to officials that their expertise has been pushed aside in COVID-19 response plans.